Pediatric Neurology
Volume 37, Issue 2 , Pages 121-126 , August 2007

Risk Factors for Pediatric Stroke: Consequences for Therapy and Quality of Life

Received 25 January 2007 ,Accepted 5 April 2007.

References 

  1. deVeber G, Roach ES, Riela AR, Wiznitzer M. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol. 2000;7:309–317
  2. Steinlin M, Pfister I, Pavlovic J, et al. Swiss Societies of Paediatric Neurology and Neonatology The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics. 2005;36:90–97
  3. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics. 2004;114:e206–e212
  4. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol. 1995;48:1343–1348
  5. Lynch JK, Han CJ, Nee LE, Nelson KB. Prothrombotic factors in children with stroke or porencephaly. Pediatrics. 2005;116:447–453
  6. Zenz W, Bodo Z, Plotho J, Streif W, et al. Factor V Leiden and prothrombin gene G20210A variant in children with ischemic stroke. Thromb Haemost. 1998;80:763–766
  7. Kenet G, Sadetzki S, Murad H, et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000;31:1283–1288
  8. Nowak-Göttl U, Sträter R, Heinecke A, et al. A. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylene tetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood. 1999;94:3678–3682
  9. von Depka M, Nowak-Göttl U, Eisert R, et al. Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood. 2000;96:3364–3368
  10. van Beynum IM, Smeitink JA, den Heijer M, te Poele Pothoff MT, Blom HJ. Hyperhomocysteinemia: a risk factor for ischemic stroke in children. Circulation. 1999;99:2070–207227
  11. Chabrier S, Husson B, Lasjaunias P, Landrieu P, Tardieu M. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol. 2000;15:290–294
  12. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation for factors in children with arterial ischemic stroke. Ann Neurol. 2003;53:167–173
  13. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella ateriopathy of childhood: natural history of vascular stenosis. Neurology. 2005;64:660–663
  14. Diener HC Kommission Leitlinien der Deutschen Gesellschaft für Neurologie (DGN) Deutsche Schlaganfallgesellschaft (DSG). Leitlinie Primär- und Sekundärprävention der zerebralen Ischämie. [In German] In:  Diener HC editors. Leitlinien für Diagnostik und Therapie in der Neurologie. 3rd edition. Stuttgart; New York: Georg Thieme Verlag; 2005;p. 192–214[Guidelines for diagnostics and therapy in neurology]. [Available at http://www.dsg-info.de/
  15. Sträter R, Becker S, von Eckardstein A, et al. Prospective assessment of risk factors for recurrent stroke in childhood: a 5-year follow-up study. Lancet. 2002;360:1540–1545
  16. DeVeber G. In pursuit of evidence-based treatments for pediatric stroke: the UK and Chest guidelines. Lancet Neurol. 2005;4:432–436
  17. Ganesan V, Ng V, Chong WK, Kirkham FJ, Connelly A. Lesion volume, lesion location, and outcome after middle cerebral artery territory stroke. Arch Dis Child. 1999;81:295–300
  18. Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham FJ. Outcome after ischaemic stroke in childhood. Dev Med Child Neurol. 2000;42:455–461
  19. In:  Weiss RH editors. Grundintelligenztest Skala 2, CFT-20. Göttingen, Toronto, Zürich: Verlag für Psychologie; 1987;
  20. In:  Melchers P,  Preuss U,  Kaufman AS,  Kaufman NL editor. Deutschsprachige Fassung von Kaufman-Assessment Battery for Children. Lisse, Netherlands: Swets & Zeitlinger; 1994;1994.
  21. In:  Raven JC editors. Guide to using the Coloured Progressive Matrices Sets A, Ab, and B. Reprint edition. Dumfries, Scotland: Grieve; 1973;
  22. Landgraf JM, Maunsell E, Speechley KN, et al. Canadian-French, German and UK versions of the Child Health Questionnaire: methodology and preliminary item scaling results. Qual Life Res. 1998;7:433–445
  23. Osganian SK, Stampfer MJ, Spiegelman D, et al. Distribution of and factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA. 1999;281:1189–1196
  24. Williams CL, Hayman LL, Daniels SR, et al. American Heart Association Cardiovascular health in childhood: a statement for health professionals from the Committee on Artherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council of Cardiovascular Disease in the Young. Circulation. 2002;106:143–160
  25. deVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J Child Neurol. 2000;15:316–324
  26. Barreirinho S, Ferro A, Santos M, et al. Inherited and acquired risk factors and their combined effects in pediatric stroke. Pediatr Neurol. 2003;28:134–138
  27. The Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022
  28. Zahuranec DB, Brown DL, Lisabeth DL, Morgenstern LB. Is it time for a large, collaborative study of pediatric stroke?. Stroke. 2005;36:1825–1829

PII: S0887-8994(07)00155-5

doi: 10.1016/j.pediatrneurol.2007.04.005

Pediatric Neurology
Volume 37, Issue 2 , Pages 121-126 , August 2007

Article Tools